Last reviewed · How we verify
Loprinone (OLPRINONE)
Loprinone (generic name: OLPRINONE) is a olprinone drug. It is currently FDA-approved for Acute heart failure.
Loprinone is a small molecule with synonyms including LOPRINONE, OLPRINONA, and OLPRINONE.
At a glance
| Generic name | OLPRINONE |
|---|---|
| Drug class | olprinone |
| Target | Phosphodiesterase 3 |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Approved indications
- Acute heart failure
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Loprinone CI brief — competitive landscape report
- Loprinone updates RSS · CI watch RSS
Frequently asked questions about Loprinone
What is Loprinone?
Loprinone (OLPRINONE) is a olprinone drug, indicated for Acute heart failure.
What is Loprinone used for?
Loprinone is indicated for Acute heart failure.
What is the generic name of Loprinone?
OLPRINONE is the generic (nonproprietary) name of Loprinone.
What drug class is Loprinone in?
Loprinone belongs to the olprinone class. See all olprinone drugs at /class/olprinone.
What development phase is Loprinone in?
Loprinone is FDA-approved (marketed).
What does Loprinone target?
Loprinone targets Phosphodiesterase 3 and is a olprinone.
Related
- Drug class: All olprinone drugs
- Target: All drugs targeting Phosphodiesterase 3
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Acute heart failure
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing